Clinical Trial Update: A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating WSD0922-FU in C797S+ advanced non-small cell lung cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• WSD0922-FU (WSD0922-FU)

Snippet

Sponsor: Wayshine Biopharm, Inc. | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING